Savara
SVRA
#5877
Rank
S$1.56 B
Marketcap
S$7.63
Share price
-2.16%
Change (1 day)
170.63%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Savara's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 -S$0.16 Billion23.94%
2024 -S$0.13 Billion75.29%
2023 -S$70.73 Million43.38%
2022 -S$49.34 Million-11.31%
2021 -S$55.63 Million-13.3%
2020 -S$64.16 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$88.86 Million105.54%
2017 -S$43.24 Million34.11%
2016 -S$32.24 Million-37.43%
2015 -S$51.52 Million38.81%
2014 -S$37.12 Million33.62%
2013 -S$27.78 Million38.49%
2012 -S$20.06 Million24.59%
2011 -S$16.1 Million-36.5%
2010 -S$25.36 Million-3.14%
2009 -S$26.18 Million-23.28%
2008 -S$34.12 Million8.52%
2007 -S$31.44 Million-34.14%
2006 -S$47.74 Million184.43%
2005 -S$16.79 Million90.75%
2004 -S$8.8 Million190.35%
2003 -S$3.04 Million11.64%
2002 -S$2.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 34.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.48 Million-84.72%๐Ÿ‡บ๐Ÿ‡ธ USA